Skip to main content

Category: Daxxify neurotoxin

Request A Consultation

September 16, 2022 | BOTOX® Cosmetic, Daxxify neurotoxin

Daxxify neurotoxin recently FDA-approved for frown line treatment

Biotechnology company Revance  issued a press release this month announcing the FDA approval of Daxxify  (DaxibotulinumtoxinA-Ianm) for the treatment of frown lines.  Findings from clinical trials using Daxxify found the average duration of action of the neurotoxin at approximately 6 months, compared to 3~4 months of other neurotoxins, such as Botox  and Dysport, while enjoying a similar safety profile.  This is very […]

Read More